表紙
市場調查報告書

血糖值檢驗用測試紙:醫療設備的開發平台評估

Blood Glucose Test Strips - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 635167
出版日期 內容資訊 英文 95 Pages
訂單完成後即時交付
價格
Back to Top
血糖值檢驗用測試紙:醫療設備的開發平台評估 Blood Glucose Test Strips - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年07月05日內容資訊: 英文 95 Pages
簡介

本報告提供全球血糖值檢驗用測試紙 (試驗帶)的市場上,主要開發中產品與其臨床實驗的進展調查,產品特性比較分析 (臨床實驗的進展各階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (資本交易、事業聯盟等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 血糖值檢驗用測試紙概要

第3章 現在臨床實驗中的產品

透過
  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認時期

第4章 在血糖值檢驗用測試紙:各企業臨床實驗中的開發中產品

  • 血糖值檢驗用測試紙的企業:各臨床實驗階段的開發中產品
  • 血糖值檢驗用測試紙:各臨床實驗階段的開發中產品

第5章 血糖值檢驗用測試紙的企業、產品概要

  • Accessible Diagnostics LLC
  • Achira Labs Pvt Ltd
  • DirectSens GmbH
  • Gluco-Chaser Inc
  • PharmaTech Solutions Inc

第6章 血糖值檢驗用測試紙市場:目前的趨勢 (全34件)

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0783EPD

GlobalData's Medical Devices sector report, "Blood Glucose Test Strips - Medical Devices Pipeline Assessment, 2019" provides an overview of Blood Glucose Test Strips currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Test Strips pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Blood Glucose Test Strips under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Blood Glucose Test Strips and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Blood Glucose Test Strips under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Blood Glucose Test Strips Overview

3 Products under Development

  • 3.1 Blood Glucose Test Strips - Pipeline Products by Stage of Development
  • 3.2 Blood Glucose Test Strips - Pipeline Products by Territory
  • 3.3 Blood Glucose Test Strips - Pipeline Products by Regulatory Path
  • 3.4 Blood Glucose Test Strips - Pipeline Products by Estimated Approval Date

4 Blood Glucose Test Strips - Pipeline Products under Development by Companies

  • 4.1 Blood Glucose Test Strips Companies - Pipeline Products by Stage of Development
  • 4.2 Blood Glucose Test Strips - Pipeline Products by Stage of Development

5 Blood Glucose Test Strips Companies and Product Overview

  • 5.1 Accessible Diagnostics LLC Company Overview
  • 5.2 Achira Labs Pvt Ltd Company Overview
  • 5.3 DirectSens GmbH Company Overview
  • 5.4 Gluco-Chaser Inc Company Overview
  • 5.5 PharmaTech Solutions Inc Company Overview

6 Blood Glucose Test Strips- Recent Developments

  • 6.1 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee
  • 6.2 Jun 11, 2019: Regulators demand more details on Roche's $4.8bn Spark acquisition
  • 6.3 May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation
  • 6.4 May 22, 2019: Serving the needs of the medical front and creating new value the start of a New Medical Device and Reagent Brand: "The Lab"
  • 6.5 May 20, 2019: LifeScan Names Ty Lee Head of Marketing
  • 6.6 May 09, 2019: Senseonics Holdings reports first quarter 2019 financial results
  • 6.7 May 09, 2019: DECN sets plan to make upcoming patent infringement appeal hearing and mediation with Johnson & Johnson a foundation for substantial recovery
  • 6.8 Apr 26, 2019: Nationally recognized expert in consumerism joins Henry Ford Health System
  • 6.9 Apr 23, 2019: In Prelude to probable transaction DECN decides to infuse its outre' precise, TBG technology to its GenChoice Test Strip, now in FDA 510k review
  • 6.10 Apr 23, 2019: Universal Biosensors: Commentary on Q1 2019 appendix 4C cash flow summary
  • 6.11 Apr 17, 2019: DECN expands talks involving its GenUltimate TBG System, balances potential and competing outcomes with recent intro to 2nd interested party
  • 6.12 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year
  • 6.13 Apr 17, 2019: Abbott reports first-quarter 2019 results
  • 6.14 Apr 09, 2019: Henry Ford Health System names two new senior leaders
  • 6.15 Apr 08, 2019: LifeScan names Brian Heald as its new Head of Product
  • 6.16 Apr 01, 2019: Mologic expands US and UK operations
  • 6.17 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips
  • 6.18 Mar 19, 2019: Abbott introduces new digital service in India as part of its global a: care program
  • 6.19 Mar 13, 2019: EKF Diagnostics Holdings: Final results
  • 6.20 Mar 08, 2019: Universal Biosensors announces resignation of CEO Rick Legleiter
  • 6.21 Mar 06, 2019: Senseonics Holdings appoints Francine R. Kaufman, M.D. as chief medical officer
  • 6.22 Feb 22, 2019: Abbott planning $62M expansion in Columbus, adding 38 jobs
  • 6.23 Feb 05, 2019: Confluent Medical Technologies launches the high-performance nitinol tubing center of excellence
  • 6.24 Jan 31, 2019: Roche reports very strong results in 2018
  • 6.25 Jan 30, 2019: DECN subsidiary receives 510k submission and ''K'' numbers from FDA CDRH for Its Genchoice! Test Strip at the close of the government shutdown
  • 6.26 Jan 29, 2019: Universal Biosensors: Commentary on FY 2018
  • 6.27 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
  • 6.28 Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019
  • 6.29 Jan 21, 2019: ARKRAY USA launches Assure Slide swallowing aid
  • 6.30 Jan 10, 2019: ARKRAY Commences Overseas Remote Maintenance Services for Medical Devices
  • 6.31 Jan 09, 2019: STANDARD GlucoNavii GDH now available for newborn testing
  • 6.32 Jan 07, 2019: Senseonics Holdings names Jon D. Isaacson as chief financial officer
  • 6.33 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager
  • 6.34 Dec 20, 2018: Strengthening Global Research and Development Networks AI Software Development facility established in India
  • 6.35 Dec 20, 2018: Universal Biosensors provides business update
  • 6.36 Dec 19, 2018: DECN Subsidiaries Appeal Nevada District Court Trial Judge's Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)
  • 6.37 Dec 17, 2018: DECN Engages second Korean manufacturing partner to raise its factory capacity by two million boxes of ''GEN'' test strips annually
  • 6.38 Dec 10, 2018: New member proposed for election to Roche Board of Directors
  • 6.39 Dec 10, 2018: ARKRAY USA changes name of long-term care division to professional healthcare division
  • 6.40 Dec 10, 2018: Roche names William Anderson as CEO
  • 6.41 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019
  • 6.42 Dec 04, 2018: DECN receives completed clinical trials report from its IRB and anticipates filing its U.S. FDA 510k application for its Genchoice! Product
  • 6.43 Dec 04, 2018: ARKRAY expands to its 13th Country with a new branch in Dubai
  • 6.44 Dec 03, 2018: Senseonics Holdings announces retirement of Chief Financial Officer
  • 6.45 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent
  • 6.46 Nov 26, 2018: Henry Ford Health System announced Dr. Betty Chu appointments
  • 6.47 Nov 08, 2018: Senseonics Holdings reports third quarter 2018 financial results
  • 6.48 Nov 07, 2018: LifeScan unveils new name and branding for the LifeScan Diabetes Institute
  • 6.49 Nov 06, 2018: DECN receives completed clinical trial data, charts and spreadsheets essential for its imminent Genchoice! Test Strip
  • 6.50 Oct 30, 2018: Universal Biosensors releases Q3 FY2018 results
  • 6.51 Oct 17, 2018: Roche reports very strong growth in the first nine months of 2018
  • 6.52 Oct 17, 2018: Roche reports sales growth as new drugs ease pressure from biosimilar competition
  • 6.53 Oct 17, 2018: Abbott Reports Third-Quarter 2018 Results
  • 6.54 Oct 15, 2018: Abbott names Robert B. Ford President, Chief Operating Officer
  • 6.55 Oct 03, 2018: J&J concludes sale of LifeScan to Platinum Equity for $2.1bn
  • 6.56 Sep 19, 2018: EKF Diagnostics: Half yearly report
  • 6.57 Sep 13, 2018: Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the tenth year running
  • 6.58 Sep 13, 2018: Abbott is named global industry leader in sustainability for the sixth consecutive year on the Dow Jones Sustainability Index (DJSI)
  • 6.59 Aug 24, 2018: Cadila Healthcare's Biologics manufacturing facility successfully completes USFDA inspection
  • 6.60 Aug 14, 2018: DECN announces significant updates for products and programs
  • 6.61 Aug 14, 2018: DECN Announces Significant Updates For Products And Programs
  • 6.62 Aug 08, 2018: Senseonics Holdings reports second quarter 2018 financial results
  • 6.63 Aug 01, 2018: Global Healthcare Organizations join Abbott to launch the UNIVANTS of Healthcare Excellence Award
  • 6.64 Jul 26, 2018: Roche reports very strong performance in the first half of 2018
  • 6.65 Jul 19, 2018: Universal Biosensors Announces Q2 Appendix 4C Cash F low Summary
  • 6.66 Jul 18, 2018: Abbott reports second-Quarter 2018 Results

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Table 1: Blood Glucose Test Strips - Pipeline Products by Stage of Development
  • Table 2: Blood Glucose Test Strips - Pipeline Products by Territory
  • Table 3: Blood Glucose Test Strips - Pipeline Products by Regulatory Path
  • Table 4: Blood

List of Figures

  • Figure 1: Blood Glucose Test Strips - Pipeline Products by Stage of Development
  • Figure 2: Blood Glucose Test Strips - Pipeline Products by Territory
  • Figure 3: Blood Glucose Test Strips - Pipeline Products by Regulatory Path
  • Figure 4: B
Back to Top